Neuroscience
  • Article
  • Aug 26 2021

A new research study suggests that higher intake of specific nutrients can be associated with lower brain iron concentration and better cognitive performance in older adults.

  • Article
  • Aug 18 2021

The University of Kentucky Spinal Cord and Brain Injury Research Center (SCoBIRC) hosted a symposium last week featuring its first class of African American Research Training Scholars (AARTS).

  • Article
  • Jul 1 2021

The Human Development Institute (HDI) will be leading an effort to improve capacity of health care to serve children with neurodevelopmental disabilities and their families throughout Kentucky.

  • Article
  • Jun 30 2021

The Research Priority Area supports a "collaborative matrix," bringing together diverse groups of investigators, trainees and research groups from nine different colleges across the university campus.

  • Article
  • Jun 24 2021

The grant will allow coordination and expansion of existing efforts to improve stroke-related health outcomes.

  • Article
  • Jun 4 2021

UK Neuroscience Professor Greg Gerhardt's new research program will provide answers to questions about the role of neurotransmitters in the progression of Alzheimer’s disease.

  • Article
  • May 26 2021

The discovery could yield a key insight which could have broad implications for understanding neurological changes associated with aging.

  • Article
  • Apr 16 2021

Goldstein also is co-director of the Kentucky Neuroscience Institute, co-director of the UK Neuroscience Research Priority Area and interim director of the UK-Norton Healthcare Stroke Care Network. Goldstein’s two-year term on the board of directors begins later this month.

  • Article
  • Mar 1 2021

Hyperbaric oxygen treatment (HBO) is a treatment that is now being experimentally studied in adult patients with severe traumatic brain injuries (TBI). Hyperbaric oxygen treatment is a specialized way, using a pressure chamber, to dramatically increase the amount of oxygen delivered to body tissues.

  • Article
  • Jan 21 2021

Florin Despa says that a major scientific goal is to understand whether the same factors that are involved in age-related metabolic disorders such as type-2 diabetes may also play a role in the development and progression of cognitive decline and dementia.